Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study

NCT02578394 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Gout
Chronic Kidney Diseases

Interventions

DRUG: Anakinra 100mg and Placebo Depo-Medrone
DRUG: Depo-Medrone 120mg and Placebo (Anakinra)

Sponsor

Mid and South Essex NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]